• Facebook
  • Twitter
  • Linked In
  • Google+
back top
Cellular & Engineered Tissue Therapies

1300 members from 70 countries Join ICRS

Cellular & Engineered Tissue Therapies

Cellular and Engineered Tissue Therapies Survey

Did you treat patients in Europe in 2013 with cellular or engineered tissue therapies (i.e., any clinical treatment based on living cells excluding DLI, donor lymphocyte infusions, and hematopoietic stem cells for hematological reconstitution)?

If so please complete the simple survey form (pdf or excel format) and send it to Helen Baldomero as soon as possible by E mail: or by fax: + 41 61 265 2735 and help bring an effective impact on the scientific, clinical and regulatory aspects of the quickly evolving sector of cellular and engineered tissue therapy.

Background to the survey
In 2008, 5 societies joined forces to establish a survey on “novel cellular therapies”:

The survey is designed to establish a comprehensive, quantitative map of patients being treated in Europe with cellular and engineered tissue therapies and also integrates the original EBMT activity survey capturing hematopoietic stem cells transplants in Europe. The report includes the number of treated patients, without any reference to their clinical outcome, information on specific cells types, processes and delivery modes in use. A yearly publication presents the data, summarizes the trends and lists in the appendix the names of the participating teams.

Cellular & Engineered Tissue Therapies in Europe 2008 – 2011

If you know of any team that is performing such therapies please forward this webpage to them and encourage them to participate.

Need help to complete the form?
The guidelines for reporting data (updated) indicate what information is needed in each part of the form. Please read them carefully before completing the survey.

If you want to submit the form electronically, please save the file to your desktop and remember to save it again after completing the data fields. It will help us if you name the file NCT Survey 2013 and then add the name of your institution at the end of the file name. Attach the form to an email and send it to

Thank you for contributing to the success of this program and to a more transparent development of the field!


Cellular and Engineered Tissue…
Cellular & Engineered Tissue Therapies